RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Oral vinorelbine in elderly or unfit patients with metastatic NSCLC
2009-01-01 Stumbo, L; Gori, B; Del Signore, E; De Sanctis, R; De Filippis, L; Fratellizzi, V; Lapadula, V; D’Antoni, I; Adua, D; Di Seri, M; Longo, F
Palonosetron plus three-day aprepitant and dexamethasone schedule to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy
2009-01-01 De Sanctis, R; Longo, F; Mansueto, G; Lapadula, V; Grande, R; Quadrini, S; Gori, B; Altavilla, A; D’Antoni, I; Del Signore, E; Stumbo, L; Cimadon, B; Cortesi, E; Gamucci, T; Di Seri, M
Palonosetron plus three-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy
2010-01-01 Longo, F; Mansueto, G; De Sanctis, R; Lapadula, V; Quadrini, S; Grande, R; Gori, B; Altavilla, A; Adua, D; Del Signore, E; Stumbo, L; De Luca, C; Cimadon, B; Cortesi, E; Gamucci, T; Di Seri, M
Perfusion Computed Tomography as prognostic and predictive factor in patients with colorectal cancer liver metastases treated with bevacizumab
2010-01-01 De Sanctis, R; Quadrini, S; Longo, F; Del Signore, E; Gori, B; Stumbo, L; Adua, D; Sollazzo, P; Manganaro, L; Di Seri, M
PERFUSION COMPUTED TOMOGRAPHY AS PROGNOSTIC AND PREDICTIVE FACTOR IN PATIENTS WITH COLORECTAL CANCER LIVER METASTASES TREATED WITH BEVACIZUMAB
2010-01-01 De Sanctis, R; Quadrini, S; Longo, F; Del Signore, E; Gori, B; Stumbo, L; Adua, D; Sollazzo, P; Manganaro, L; Di Seri, M
Phase I, pharmacokinetic (PK), pharmacodynamic (PD) study of lapatinib (L) in combination with sorafenib (S) in patients with advanced refractory solid tumors
2011-01-01 Simonelli, M; Zucali, Pa; De Sanctis, R; Lorenzi, E; De Vincenzo, F; Rimassa, L; Tronconi, Mc; Personeni, N; Masci, G; Zuradelli, M; Perrino, M; Bertossi, M; Giordano, L; Santoro, A
Phase I, Pharmacokinetics (PK), Pharmacodynamic (PD) Study of Lapatinib (L) in Combination With Sorafenib (S) in Patients With Advanced Refractory Solid Tumours
2011-01-01 Simonelli, M; Zucali, Pa; De Sanctis, R; Lorenzi, E; De Vincenzo, F; Rimassa, L; Tronconi, Mg; Zuradelli, M; Giordano, L; Santoro, A
Phase I, pharmacokinetics, pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors
2011-01-01 Simonelli, M; Zucali, Pa; De Sanctis, R; Lorenzi, E; De Vincenzo, F; Rimassa, L; Tronconi, Mc; Personeni, N; Masci, G; Zuradelli, M; Giordano, L; Santoro, A
Phase II study: Docetaxel-cisplatin and pro drug tegafur (TPF) as neoadjuvant treatment in advanced patients with head and neck cancer (HNC): Results and correlation between tandem magnesium/creatinine and toxicity
2012-01-01 Ortega, Ms; Esquerdo, G; Cervera Grau, Jm; Barrajon, E; Rodriguez Villalva, S; De Piaggio, M; Peiro, R; De Sanctis, R; Paz Espinoza Venegas, M
Safety and efficacy of bevacizumab with first-line FOLFIRI for metastatic colorectal cancer: single center experience
2008-01-01 Longo, F; De Sanctis, R; Quadrini, S; Stumbo, L; Del Signore, E; Gori, B; De Filippis, L; Di Seri, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Oral vinorelbine in elderly or unfit patients with metastatic NSCLC | 1-gen-2009 | Stumbo, L; Gori, B; Del Signore, E; De Sanctis, R; De Filippis, L; Fratellizzi, V; Lapadula, V; D’Antoni, I; Adua, D; Di Seri, M; Longo, F | |
| Palonosetron plus three-day aprepitant and dexamethasone schedule to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy | 1-gen-2009 | De Sanctis, R; Longo, F; Mansueto, G; Lapadula, V; Grande, R; Quadrini, S; Gori, B; Altavilla, A; D’Antoni, I; Del Signore, E; Stumbo, L; Cimadon, B; Cortesi, E; Gamucci, T; Di Seri, M | |
| Palonosetron plus three-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy | 1-gen-2010 | Longo, F; Mansueto, G; De Sanctis, R; Lapadula, V; Quadrini, S; Grande, R; Gori, B; Altavilla, A; Adua, D; Del Signore, E; Stumbo, L; De Luca, C; Cimadon, B; Cortesi, E; Gamucci, T; Di Seri, M | |
| Perfusion Computed Tomography as prognostic and predictive factor in patients with colorectal cancer liver metastases treated with bevacizumab | 1-gen-2010 | De Sanctis, R; Quadrini, S; Longo, F; Del Signore, E; Gori, B; Stumbo, L; Adua, D; Sollazzo, P; Manganaro, L; Di Seri, M | |
| PERFUSION COMPUTED TOMOGRAPHY AS PROGNOSTIC AND PREDICTIVE FACTOR IN PATIENTS WITH COLORECTAL CANCER LIVER METASTASES TREATED WITH BEVACIZUMAB | 1-gen-2010 | De Sanctis, R; Quadrini, S; Longo, F; Del Signore, E; Gori, B; Stumbo, L; Adua, D; Sollazzo, P; Manganaro, L; Di Seri, M | |
| Phase I, pharmacokinetic (PK), pharmacodynamic (PD) study of lapatinib (L) in combination with sorafenib (S) in patients with advanced refractory solid tumors | 1-gen-2011 | Simonelli, M; Zucali, Pa; De Sanctis, R; Lorenzi, E; De Vincenzo, F; Rimassa, L; Tronconi, Mc; Personeni, N; Masci, G; Zuradelli, M; Perrino, M; Bertossi, M; Giordano, L; Santoro, A | |
| Phase I, Pharmacokinetics (PK), Pharmacodynamic (PD) Study of Lapatinib (L) in Combination With Sorafenib (S) in Patients With Advanced Refractory Solid Tumours | 1-gen-2011 | Simonelli, M; Zucali, Pa; De Sanctis, R; Lorenzi, E; De Vincenzo, F; Rimassa, L; Tronconi, Mg; Zuradelli, M; Giordano, L; Santoro, A | |
| Phase I, pharmacokinetics, pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors | 1-gen-2011 | Simonelli, M; Zucali, Pa; De Sanctis, R; Lorenzi, E; De Vincenzo, F; Rimassa, L; Tronconi, Mc; Personeni, N; Masci, G; Zuradelli, M; Giordano, L; Santoro, A | |
| Phase II study: Docetaxel-cisplatin and pro drug tegafur (TPF) as neoadjuvant treatment in advanced patients with head and neck cancer (HNC): Results and correlation between tandem magnesium/creatinine and toxicity | 1-gen-2012 | Ortega, Ms; Esquerdo, G; Cervera Grau, Jm; Barrajon, E; Rodriguez Villalva, S; De Piaggio, M; Peiro, R; De Sanctis, R; Paz Espinoza Venegas, M | |
| Safety and efficacy of bevacizumab with first-line FOLFIRI for metastatic colorectal cancer: single center experience | 1-gen-2008 | Longo, F; De Sanctis, R; Quadrini, S; Stumbo, L; Del Signore, E; Gori, B; De Filippis, L; Di Seri, M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 4 Contributo in Atti di Convegno ... 28
- 4 Contributo in Atti di Convegno ... 12
- 4 Contributo in Atti di Convegno ... 10
- 4 Contributo in Atti di Convegno ... 6
Data di pubblicazione
- 2020 - 2022 1
- 2010 - 2019 10
- 2007 - 2009 17
Editore
- Oxford University Press 3
- OXFORD UNIV PRESS, GREAT CLARENDO... 2
- OXFORD UNIV PRESS 1
Rivista
- ANNALS OF ONCOLOGY 21
- JOURNAL OF CLINICAL ONCOLOGY 4
- EUROPEAN JOURNAL OF CANCER 1
- EUROPEAN JOURNAL OF CANCER. SUPPL... 1
Lingua
- eng 7
Accesso al fulltext
- no fulltext 26
- reserved 2